Securities code: Jiangsu Chinagreen Biological Technology Co.Ltd(300970) securities abbreviation: Jiangsu Chinagreen Biological Technology Co.Ltd(300970) Announcement No.: 2022020 Jiangsu Chinagreen Biological Technology Co.Ltd(300970)
Announcement on the remuneration of directors, supervisors and senior managers in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
According to Jiangsu Chinagreen Biological Technology Co.Ltd(300970) (hereinafter referred to as “the company”), the articles of association, the detailed rules for the work of the remuneration and assessment committee and other relevant systems, combined with the actual situation of the company’s business scale and with reference to the industrial remuneration level, the company formulates the remuneration plan for directors, supervisors and senior managers in 2022. The 12th meeting of the 4th board of directors and the 12th meeting of the 4th board of supervisors were held on April 8, 2022, and the proposal on the remuneration scheme of the company’s senior managers in 2022, the proposal on the remuneration scheme of the company’s directors in 2022 and the proposal on the remuneration scheme of the company’s supervisors in 2022 were considered and adopted. Relevant proposals need to be submitted to the general meeting of shareholders of the company for deliberation. The details are hereby announced as follows:
1、 Applicable object and period
Applicable to: directors, supervisors and senior managers
Applicable period: the applicable period of the remuneration of directors and supervisors is from the date of deliberation and approval of the company’s general meeting of shareholders to the date of approval of the new remuneration scheme; The applicable period of this senior management compensation scheme is from the date of deliberation and approval by the board of directors to the date of approval of the new compensation scheme.
2、 Salary standard
1. Remuneration scheme for directors of the company:
(1) Non independent directors holding management positions in the company shall receive remuneration according to the relevant contracts signed with the company and in combination with their actual positions and work contents in the company, enjoy various social insurance and other welfare benefits of the company, and do not receive director allowance separately.
(2) A non independent director who has signed a written employment agreement with the company on his position as a director and has not held any management position in the company will not receive any salary and allowance from the company or enjoy any welfare treatment in the company. (3) The remuneration of the independent directors of the company is 60000 yuan / year (before tax), and they will no longer receive other remuneration or enjoy other welfare benefits from the company. The allowance of the independent directors is paid on a monthly basis.
2. Remuneration scheme for supervisors:
Supervisors serving in the company shall receive remuneration according to the relevant contracts signed with the company and in combination with the actual positions and work contents of the company, enjoy various social insurance and other welfare benefits of the company, and do not receive supervisor allowance separately.
3. Senior management compensation scheme:
The senior managers working in the company shall be evaluated according to the company’s current salary management system, actual work performance and combined with the company’s business performance, and the evaluation results shall finally determine the basis of salary.
3、 Other provisions
1. The remuneration scheme of directors and supervisors in 2022 shall be implemented after being submitted to the general meeting of shareholders of the company for deliberation and approval, and the remuneration of senior managers in 2022 shall be implemented after being reviewed and approved by the board of directors of the company.
2. The remuneration of directors, supervisors and senior managers in the company shall be paid monthly according to the relevant contracts signed with the company and the company’s remuneration management system; The allowance for independent directors is also paid on a monthly basis.
3. The remuneration of the company’s directors, supervisors and senior management personnel shall be paid in accordance with the company’s remuneration system for the reason of their resignation, change of tenure and other reasons.
4. The individual income tax related to the above salary or allowance shall be uniformly withheld and paid by the company.
5. The expenses actually incurred by directors, supervisors and senior managers due to attending the company’s meetings shall be reimbursed by the company.
4、 Opinions of independent directors
After verification, the independent directors believe that the remuneration scheme of directors and senior managers in 2022 complies with the articles of association and relevant laws and regulations, conforms to the actual operation of the company, is conducive to strengthening the diligence of directors and senior managers, encouraging the management to improve work efficiency, and is conducive to the sustainable and stable development of the company. The independent directors unanimously agreed on this remuneration scheme and agreed that the remuneration scheme of directors in this matter should be submitted to the general meeting of shareholders for deliberation.
Independent directors are not required to express independent opinions on the remuneration scheme of supervisors.
5、 Documents for future reference
1. Resolutions of the 12th meeting of the 4th board of directors;
2. Resolutions of the 12th meeting of the 4th board of supervisors; 3. Independent opinions of independent directors on matters related to the 12th meeting of the Fourth Board of directors. It is hereby announced.
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) board of directors April 8, 2022
